{"id":"placebo-bupropion-placebo-gum","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL1201735","moleculeType":"Small molecule","molecularWeight":"320.66"},"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=Placebo bupropion-Placebo gum","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T06:47:58.786146+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T06:48:03.979612+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=Placebo bupropion-Placebo gum","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T06:48:04.309910+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: Norepinephrine transporter inhibitor","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T06:48:05.384685+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201735/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T06:48:05.033202+00:00"}},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebo bupropion-placebo gum serves as a control arm in clinical trials, allowing researchers to isolate the true therapeutic effect of active bupropion by comparing outcomes against an inert treatment. Since both components are placebos, this formulation produces no pharmacological effect and is used solely for blinding and comparative study purposes.","oneSentence":"This is a placebo control formulation combining inactive bupropion and placebo gum used in clinical research to assess the efficacy of active bupropion treatment.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:00:37.063Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T06:48:06.593959+00:00","fieldsConflicting":0,"overallConfidence":0.95},"indications":{"approved":[{"name":"Clinical trial control arm (not a therapeutic indication)"}]},"trialDetails":[{"nctId":"NCT00063323","phase":"PHASE3","title":"Maintenance Treatment for Abstinent Smokers","status":"COMPLETED","sponsor":"National Institute on Drug Abuse (NIDA)","startDate":"2000-08","conditions":"Tobacco Use Disorder","enrollment":589},{"nctId":"NCT00307203","phase":"PHASE4","title":"Safety and Effectiveness of Sustained Release Bupropion in Treating Individuals With Schizophrenia Who Smoke","status":"COMPLETED","sponsor":"National Institute on Drug Abuse (NIDA)","startDate":"1998-08","conditions":"Tobacco-Use Disorder, Schizophrenia, Psychotic Disorders","enrollment":51},{"nctId":"NCT01621022","phase":"PHASE4","title":"Bupropion Alone or Combined With Nicotine Gum","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2001-01","conditions":"Tobacco Dependence","enrollment":608},{"nctId":"NCT00320697","phase":"PHASE4","title":"Smoking Relapse Prevention in Schizophrenia","status":"COMPLETED","sponsor":"North Suffolk Mental Health Association","startDate":"2006-04","conditions":"Schizophrenia, Schizoaffective Disorder, Smokers","enrollment":25}],"_emaApprovals":[],"_faersSignals":[],"crossReferences":{"chemblId":"CHEMBL1201735"},"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Placebo bupropion-Placebo gum","genericName":"Placebo bupropion-Placebo gum","companyName":"University of Wisconsin, Madison","companyId":"university-of-wisconsin-madison","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This is a placebo control formulation combining inactive bupropion and placebo gum used in clinical research to assess the efficacy of active bupropion treatment. Used for Clinical trial control arm (not a therapeutic indication).","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T06:48:06.593959+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}